Clinical effectiveness and cost-effectiveness of Helicobacter pylori testing and treatment in patients receiving long-term ulcer prophylaxis.
Skog
Jilian H
JH
Veterans Affairs San Diego Health Care System (VASDHCS), San Diego, CA, USA. jilians@nmcsd.med.navy.mil
Morreale
Anthony P
AP
Plowman
Brian K
BK
Rapier
Roderick
R
Dole
Sylvia
S
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D010437:Peptic Ulcer / Q000382:microbiology / Q000517:prevention & control*; D011292:Premedication; D016896:Treatment Outcome; D014481:United States; D014728:Veterans
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents